Clinical management of brain metastasis

Journal of Neurology
C J Vecht

Abstract

Brain metastasis is a common complication occurring in about 15-20% of all cancer patients. For the initial management, distinguishing between three types of presentation is essential: de novo brain metastasis, simultaneous presentation of both brain metastasis and the primary tumour (usually lung carcinoma), and the presentation of a patient known to have systemic cancer developing a brain metastasis. For de novo brain metastasis, surgery is required, and detecting the primary tumour is of limited value. For simultaneous presentation, both a craniotomy and a thoracotomy may be indicated and may lead to cure in a number of cases. For a sequential presentation, the outcome is determined by a number of independent prognostic factors: age, performance status, and the extent of metastatic disease. In relatively young patients with a single brain metastasis, good performance status and no progression of systemic disease, treatment by either surgery or radiosurgery in combination with whole brain radiation therapy is indicated. Otherwise, as in multiple brain metastases, radiation therapy only is the main treatment. For symptomatic therapy of brain oedema or increased intracranial pressure, dexamethasone is administered. The standard...Continue Reading

References

Jul 1, 1976·The New England Journal of Medicine·R L Byyny
Jul 1, 1977·Neurology·T I Mandybur
Feb 22, 1990·The New England Journal of Medicine·R A PatchellB Young
Jul 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C FadulR G Wiley
Sep 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J B SørensenP Dombernowsky
Oct 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N CohenL Recht
Jul 1, 1988·The Annals of Thoracic Surgery·J R HankinsJ S McLaughlin
Jul 1, 1988·Archives of Neurology·J Y DelattreJ B Posner
Oct 1, 1986·The Annals of Thoracic Surgery·D J MagilliganJ I Ausman
Jan 1, 1985·Medicine·F GrausJ B Posner
Oct 18, 1985·JAMA : the Journal of the American Medical Association·D D WongM LaVergne
Oct 1, 1984·Journal of Neurology, Neurosurgery, and Psychiatry·J B ChalkM J Eadie
Sep 1, 1980·Journal of Neurosurgery·R M VoorhiesH T Thaler
Jan 4, 1995·Journal of the National Cancer Institute·E AlexanderJ S Loeffler
Mar 1, 1994·International Journal of Radiation Oncology, Biology, Physics·J C FlickingerP K Sneed
Jun 1, 1993·Annals of Neurology·C J VechtA R Wattendorff
May 1, 1996·Journal of Neurosurgery·A K BindalR Sawaya

❮ Previous
Next ❯

Citations

Dec 21, 2004·Neurosurgical Review·Andreas M StarkH Maximilian Mehdorn
May 22, 2010·Neurosurgical Review·Nikolay A PeevHirotoshi Sano
May 26, 2004·Current Treatment Options in Neurology·Suriya A. Jeyapalan, Tracy Batchelor
May 26, 2005·Cancer Treatment Reviews·Konstantinos S PolyzoidisNicholas Pavlidis
Aug 12, 1999·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Y SaitohM Kubota
Apr 5, 2001·International Journal of Radiation Oncology, Biology, Physics·P E HuberJ Debus
Jul 10, 2003·Lancet Neurology·Charles J VechtErik B Wilms
Jun 24, 1999·Japanese Journal of Clinical Oncology·A OgoseS Yoshida
Apr 11, 2002·American Journal of Clinical Oncology·Timothy F CloughesyGary L Elfring
May 23, 2002·Regional Anesthesia and Pain Medicine·Mads U WernerHenrik Kehlet
Dec 29, 2009·Journal of Neurosurgery·Akash J PatelRaymond Sawaya
Jul 5, 2007·Neurosurgical Focus·Anthony L D'Ambrosio, Siviero Agazzi
Jan 7, 2011·Pathology Research International·Andreas M Stark
May 16, 2000·Cancer Investigation·S A Jeyapalan, T T Batchelor
Sep 21, 2010·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·A M StarkH M Mehdorn
Jan 9, 2010·International Journal of Radiation Oncology, Biology, Physics·Ajay NiranjanL Dade Lunsford
Jun 21, 2008·Revue neurologique·J-S GuillamoG-L Defer
May 12, 2012·International Journal of Radiation Biology·Guillaume DesmaraisBenoit Paquette
Aug 2, 2008·Expert Opinion on Pharmacotherapy·Christos KosmasNikolaos Mylonakis
Sep 14, 2000·QJM : Monthly Journal of the Association of Physicians·D MaguireF Shanahan
May 30, 2013·Surgical Neurology International·Taylor J AbelPatrik Gabikian
Oct 6, 2006·Journal of Neuropathology and Experimental Neurology·Mark W BecherLarry E Davis
Sep 11, 2003·The Journal of Pharmacology and Experimental Therapeutics·Jiing C LuoChi H Cho
Dec 12, 2018·Acta Anaesthesiologica Scandinavica·Hitoshi TaguchiMunehiro Masuzawa

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.